Evidence map›Paper›PMID 27287376›Full record

ArticleDiabetologia2016

Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot.

Hood Thabit, Lalantha Leelarathna

Open access · hybridAbstract readComment
In one paragraph

Article in Diabetologia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Hood ThabitWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, CB2 0QQ, Cambridge, UK. ht312@medschl.cam.ac.uk.
Lalantha LeelarathnaEndocrinology and Diabetes Research Group, Institute of Human Development, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK.
Manchester Academic Health Science Centre · GBWellcome/MRC Institute of Metabolic Science · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exercise poses significant challenges to glucose management in type 1 diabetes. In spite of careful planning and manipulation of subcutaneous insulin administration, increased risk of hypoglycaemia and glycaemic variability during and after exercise may occur as a result of inherent delays in insulin action and impaired counter-regulatory hormone responses. Various strategies to mitigate this issue have been advocated in clinical practice, including ingestion of supplementary carbohydrate prior to exercise, reducing background and pre-meal insulin bolus and performing bouts of resistance/high intensity exercise before aerobic exercise. Insulin pump therapy, considered the most physiological form of insulin replacement for type 1 diabetes allows modulation of basal insulin delivery before, during and after exercise. However uncertainty remains regarding the optimal strategy to reduce basal insulin delivery and its efficacy. In this issue of Diabetologia, McAuley and colleagues (DOI: 10.1007/s00125-016-3981-9 ) report on the impact of a 50% reduction of basal insulin delivery before, during and after moderate-intensity aerobic exercise. Results from this study may contribute to a better understanding of the effects of basal insulin delivery manipulation and may aid in devising therapeutic approaches for glucose management during exercise.

Indexed as

Insulin Infusion SystemsAdultBlood GlucoseCross-Over StudiesDiabetes Mellitus, Type 1ExerciseFemaleHumansHypoglycemic AgentsInsulinMaleMiddle AgedBlood GlucoseHypoglycemic AgentsInsulinBasal insulin deliveryClinical trialContinuous subcutaneous insulin infusionExerciseHypoglycaemiaInsulin pumpType 1 diabetes

Identifiers

PMID27287376
PMCPMC4930462
OpenAlexW2411252161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.